Indivior PLC (NASDAQ:INDV) Receives Average Recommendation of “Buy” from Analysts

Indivior PLC (NASDAQ:INDV) has earned an average rating of “Buy” from the eight brokerages that are covering the company, MarketBeat reports. One analyst has rated the stock with a hold rating, five have given a buy rating and two have given a strong buy rating to the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $32.1667.

A number of brokerages have recently weighed in on INDV. Zacks Research upgraded Indivior from a “hold” rating to a “strong-buy” rating in a research report on Monday, November 3rd. Weiss Ratings reiterated a “hold (c)” rating on shares of Indivior in a research report on Friday, October 31st. Piper Sandler reaffirmed an “overweight” rating and set a $41.00 target price (up previously from $27.00) on shares of Indivior in a research note on Friday, October 31st. Craig Hallum reaffirmed a “buy” rating and issued a $41.00 price target on shares of Indivior in a research note on Friday, October 31st. Finally, Northland Securities set a $40.00 price objective on Indivior in a report on Friday, October 31st.

Indivior Stock Performance

Shares of Indivior stock opened at $32.75 on Monday. The company has a market capitalization of $4.52 billion, a P/E ratio of 52.82 and a beta of 0.68. The company has a fifty day moving average of $26.37 and a 200 day moving average of $20.45. Indivior has a fifty-two week low of $7.62 and a fifty-two week high of $33.30.

Indivior (NASDAQ:INDV) last issued its earnings results on Thursday, October 30th. The company reported $0.72 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.34. Indivior had a negative return on equity of 86.28% and a net margin of 6.65%.The company had revenue of $314.00 million for the quarter, compared to the consensus estimate of $257.66 million. Indivior has set its FY 2025 guidance at EPS. Analysts forecast that Indivior will post 1.22 EPS for the current year.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Acadian Asset Management LLC raised its stake in shares of Indivior by 124.4% during the 2nd quarter. Acadian Asset Management LLC now owns 1,492,272 shares of the company’s stock worth $21,977,000 after acquiring an additional 827,230 shares in the last quarter. State of New Jersey Common Pension Fund D acquired a new position in shares of Indivior in the 2nd quarter valued at $262,000. ProShare Advisors LLC purchased a new position in shares of Indivior in the second quarter worth about $435,000. Rathbones Group PLC raised its position in Indivior by 294.9% during the 2nd quarter. Rathbones Group PLC now owns 56,015 shares of the company’s stock worth $832,000 after buying an additional 41,831 shares during the last quarter. Finally, Landscape Capital Management L.L.C. raised its holdings in shares of Indivior by 78.1% during the first quarter. Landscape Capital Management L.L.C. now owns 140,137 shares of the company’s stock worth $1,336,000 after purchasing an additional 61,455 shares during the last quarter. 60.33% of the stock is owned by institutional investors.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.